SCHEMBL22767201

SCHEMBL22767201

N#CCOC(=O)c1ccc(C=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
ADRB2 P07550 1/20 0.48
ADRB1 P08588 1/20 0.48
ADRB3 P13945 1/20 0.48
EGFR P00533 2/20 0.46
TNKS O95271 1/20 0.43
PARP10 Q53GL7 1/20 0.42
PARP3 Q9Y6F1 1/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
RXFP1 Q9HBX9 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
SNCA P37840 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.38
ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70033 0.87 TNKS (0.50) ALDH1A1ADRB2ADRB1ADRB3TNKS
SCHEMBL13402894 0.84 CA12 (0.58) ALDH1A1ADRB2ADRB1ADRB3PARP10
SCHEMBL31384436 0.82 ALDH1A1 (0.42) ALDH1A1ADRB2ADRB1ADRB3EGFR
SCHEMBL19219007 0.81 ALDH1A1 (0.62) ALDH1A1ADRB2ADRB1ADRB3PARP10
SCHEMBL23681173 0.80 UNG (0.57) ALDH1A1TNKSRXFP1KDM4EGAA
SCHEMBL30086132 0.80 UNG (0.57) ALDH1A1TNKSRXFP1KDM4EGAA
SCHEMBL22767270 0.79 ESR1 (0.60) ALDH1A1CA12CA1CA2CA9
SCHEMBL22767273 0.78 TDP1 (0.53) ALDH1A1ADRB2ADRB1ADRB3TNKS
SCHEMBL18671095 0.78 KMT2A (0.49) ALDH1A1ADRB2ADRB1ADRB3TNKS
SCHEMBL23681041 0.78 ADRB2 (0.54) ALDH1A1ADRB2ADRB1ADRB3TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119391657-A Novel ribozyme system for catalyzing aminoacylation of tRNA and amino acid and application thereof 湖北肽环生物科技有限公司 2025-02-07 CN claimed
CN-119391657-A Novel ribozyme system for catalyzing aminoacylation of tRNA and amino acid and application thereof 湖北肽环生物科技有限公司 2025-02-07 CN disclosed
US-20220306677-A1 COMPOSITIONS AND METHODS FOR MAKING HYBRID POLYPEPTIDES YALE UNIVERSITY 2022-09-29 US disclosed
WO-2020247605-A1 COMPOSITIONS AND METHODS FOR MAKING HYBRID POLYPEPTIDES YALE UNIVERSITY (US) 2020-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306677-A1 COMPOSITIONS AND METHODS FOR MAKING HYBRID POLYPEPTIDES NSUN3, TARBP1, TRDMT1 ALDH1A1 3034/4885ADRB2 4875/4885ADRB1 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.